Anti-CDw17 Mouse Monoclonal Antibody [clone: HuLy-m13]

Supplier: Biotium

BNUB1088-100 BNUB1088-500
75909-364EA 240.92 USD
75909-364 75909-366
Anti-CDw17 Mouse Monoclonal Antibody [clone: HuLy-m13]
Antibodies
CD17 is an intermediate glycosphingolipid from the metabolism of higher gangliosides that localizes to sphingolipid-sterol rafts. CD17 is detectable in monocytes, granulocytes, basophils, platelets, a subset of peripheral B cells (CD19 ) and tonsil dendritic cells. It is rapidly down regulated on activated granulocytes and is upregulated on IL-2 activated T lymphocytes. CD17 binds to bacteria and may function in phagocytosis. VEGF-treated endothelial cells can produce CD17, which can then mediate signaling toward PECAM-1 expression and angiogenesis. Tumor necrosis factor alpha (TNFa)-induced astrogliosis (astrocyte proliferation and glial fibrillary acidic protein (GFAP) upregulation) in response to neuro-inflammation (i.e. spinal cord injury) causes an increase in intracellular levels of CD17. Aberrant levels of glycosphingolipids are a feature of cancer cells and may influence integrin clustering and internalization.

Type: Primary
Antigen: CDw17
Clonality: Monoclonal
Clone: Clone HuLy-m13
Conjugation: Unconjugated
Epitope:
Host: Mouse
Isotype: IgM
Reactivity: Human
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR